Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Sleep Loss as a Factor to Induce Cellular and Molecular Inflammatory Variations.
Serum NSE and multiple sclerosis.
[The usefulness of 3T magnetic resonance in the differential diagnosis of ischemic optic neuropathy and inflammatory optic neuritis].
Sub-analysis of geographical variations in the 2-year observational COPTIMIZE trial of patients with relapsing-remitting multiple sclerosis converting to glatiramer acetate.
Sodium channel blockers for neuroprotection in multiple sclerosis.
In Vivo Fate Imaging of Intracerebral Stem Cell Grafts in Mouse Brain.
Lymphocytic hypophysitis associated with pediatric multiple sclerosis.
Socio-economic factors and immigrant population studies of multiple sclerosis.
Estrogen-mediated protection of experimental autoimmune encephalomyelitis: Lessons from the dissection of estrogen receptor-signaling in vivo.
Does Physical Activity Change Over 24 Months in Persons With Relapsing-Remitting Multiple Sclerosis?
Adherence Associated with Oral Medications in the Treatment of Spasticity.
Store-operated Calcium Entry into B Cells Regulates Autoimmune Inflammation.
Mechanisms and therapeutic implications of the placebo effect in neurological and psychiatric conditions.
Strategies for protecting oligodendrocytes and enhancing remyelination in multiple sclerosis.
TNFR2 Deficiency Acts in Concert with Gut Microbiota To Precipitate Spontaneous Sex-Biased Central Nervous System Demyelinating Autoimmune Disease.
Statistical image analysis of longitudinal RAVENS images.
Novel composite MRI scale correlates highly with disability in multiple sclerosis patients.
Mapping search terms to review goals is essential.
Obstructive Sleep Apnea is an Under-Recognized and Consequential Morbidity in Multiple Sclerosis.
Poly(ADP-ribose) polymerase-1 inhibition in brain endothelium protects the blood-brain barrier under physiologic and neuroinflammatory conditions.
Hippocampal function is compromised in an animal model of multiple sclerosis.
Drug repurposing: a systematic approach to evaluate candidate oral neuroprotective interventions for secondary progressive multiple sclerosis.
Multiple sclerosis influences the precision of the ankle plantarflexon muscular force production.
Improved Framework for Tractography Reconstruction of the Optic Radiation.
In vivo characterization of microglial engulfment of dying neurons in the zebrafish spinal cord.
Pages
« first
‹ previous
…
681
682
683
684
685
686
687
688
689
…
next ›
last »